⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 5 hours ago ⚠ LIVE — European Consumer Safety Watch 💊 Medicines: 30 in last 7 days 🍎 Food: 2 in last 7 days 🧸 Products: 0 in last 7 days 🟢 Monitoring: EMA · RASFF · NVWA · FAGG · FAVV · EFSA · Safety Gate ⏱ Last fetch: 5 hours ago
🛡️ EUSW
💊 Medicines 🍎 Food 🧸 Products 🔎 Search
📊 Data
🏷 Brands 🌍 Countries ℹ️ About ✉ Unsubscribe
🇬🇧
🇬🇧 English 🇳🇱 Nederlands 🇫🇷 Français 🇩🇪 Deutsch 🇪🇸 Español 🇮🇹 Italiano 🇵🇹 Português 🇵🇱 Polski 🇸🇪 Svenska 🇷🇴 Română 🇨🇿 Čeština 🇫🇮 Suomi 🇩🇰 Dansk
💊 Medicine AT August 26, 2026

Emtricitabin/Tenofovir disoproxil ratiopharm 200 mg/245 mg Filmtabletten 200/245 mg (Filmtablette)

📷 Wikipedia: Emtricitabine/tenofovir · Source
Emtricitabin/Tenofovir disoproxil ratiopharm 200 mg/245 mg Filmtabletten 200/245 mg (Filmtablette)
📷 Wikipedia: Emtricitabine/tenofovir · Source
Parallel export is banned for this medicine. Supply is delayed due to manufacturing issues. The affected packs are the 30-tablet box and blister pack.
⚠️
Shortage ongoing
EMTRICITABIN is currently in short supply in AT.
📈 Timeline
15 days active so far
August 27, 2026 September 10, 2026

What is this? This is a pill used to treat virus infections. It contains two medicines: emtricitabine and tenofovir.

What's happening? The pills are not being made right now. They are out of stock.

Does this affect me? If you take this pill, you may not be able to get more.

What should I do? Ask your pharmacist or doctor for help. They can find another safe option for you.

🤖 This plain-language summary is automatically generated from the official agency notice using AI. It is for general information only — not medical advice. For decisions about your health, always consult a pharmacist or doctor and read the official source linked below.

🔬 Medical / technical details (for professionals)
Agency-published detail

🚫 Parallel export ban active · ATC: J05AR03 · Reason: Verzögerung bei der Herstellung · Marketing authorisation holder: Teva B.V., Swensweg 5, 2031 GA Haarlem, Niederlande · Affected packs: 30 Stück Schachtel, Blisterpackung [Nicht verfügbar, since 2026-08-17]

First published
August 26, 2026
Last refreshed by us
17 hours ago
Severity (as classified)
High
Official source
https://medikamente.basg.gv.at/en/medicine-shortage

All information on this page comes from the official agency notice. We translate and summarise it; we don't add or edit facts.

Related alerts

High AT 2 weeks ago

Emtricitabin/Tenofovirdisoproxil Mylan 200 mg/245 mg Filmtabletten 200 mg/245 mg (Filmtablette)

A delay affects the supply of Emtricitabin/Tenofovirdisoproxil Mylan 200 mg/245 mg film-coated tablets.

❓ Frequently asked questions

▸ What is this medicine shortage alert about?
Emtricitabin/Tenofovir disoproxil ratiopharm 200 mg/245 mg Filmtabletten 200/245 mg (Filmtablette). Parallel export is banned for this medicine. Supply is delayed due to manufacturing issues. The affected packs are the 30-tablet box and blister pack.
▸ When was this alert issued?
This alert was issued on August 26, 2026 by BASG (Austria).
▸ Which countries are affected?
The alert applies to Austria.
▸ How serious is this alert?
Serious risk. A serious risk means the product or medicine can cause significant harm. Treat the alert as urgent.
▸ What should I do?
If you take this medicine, contact your pharmacist or prescribing doctor. They can advise on alternative products or substitutes. Do not stop taking prescription medicine without medical advice.
▸ Where can I find the official notice?
The full official notice is published on medikamente.basg.gv.at.

💬 Discussion

Share your experience or ask a question. Real names and email are optional but moderation friendly.

No comments yet — be the first.

We email a confirmation link. Your address stays private.

⚠️ We aggregate official notices. We do not give medical advice. For medical or legal decisions, consult the source agency and a qualified professional.